Form 4 for CHRS Coherus Oncology, Inc.
Accepted 2022-01-12 00:00:00 ET · period of report 2022-01-10 · accession 0001567619-22-001114 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-01-12 | 2022-01-10+ | CHRS | Vexler Vladimir | CSO | F - Tax | $14.33 | -7,733 | 111.0K | -7% | -$110.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-11 | F | D | 3,583 | $14.36 | 107,421 | D | — | — | (F3) Represents the number of shares of common stock withheld to pay the related tax liability on RSUs that vested on January 11, 2022. (F4) Includes 91,249 RSUs. |
| 2 | Common | Common Stock | 2022-01-10 | F | D | 4,150 | $14.30 | 111,004 | D | — | — | (F1) Represents the number of shares of common stock withheld to pay the related tax liability on restricted stock units ("RSUs") that vested on January 10, 2022. (F2) Includes 101,666 RSUs. |